FibroBiologics
- Headquarters
- Houston, Texas
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- fibrobiologics.com
- Total Funding
- $25.0M
- Last Round
- $25.0M Corporate RoundDec 2024
About
FibroBiologics is a clinical-stage cell therapy company developing fibroblast-based treatments and potential cures for chronic autoimmune and degenerative diseases. Its pipeline targets conditions including multiple sclerosis, degenerative disc disease, osteoporosis, and burns using proprietary fibroblast cell and fibroblast-derived material technologies. The company is publicly traded on Nasdaq (FBLG) and operates a dedicated research and manufacturing laboratory in Houston, Texas.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account